C. Mannhalter

G. Heinze, R. Sunder-Plassmann, C. Mannhalter, 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

Butyrylcholinesterase activity predicts long-term survival in patients with coronary artery disease.

O. Wagner, G. Maurer, K. Huber, 2012, Clinical chemistry.

Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis.

C. Mannhalter, G. Endler, 2003, Clinica chimica acta; international journal of clinical chemistry.

The Risk of Early Recurrent Venous Thromboembolism after Oral Anticoagulant Therapy in Patients with the G20210A Transition in the Prothrombin Gene

E. Minar, S. Eichinger, P. Kyrle, 1999, Thrombosis and Haemostasis.

The P-selectin gene Pro715 allele and low levels of soluble P-selectin are associated with reduced P2Y12 adenosine diphosphate receptor reactivity in clopidogrel-treated patients.

R. Koppensteiner, C. Mannhalter, C. Ay, 2011, Atherosclerosis.

High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant.

A. Kaider, C. Mannhalter, I. Pabinger, 2007, Clinical chemistry.

The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden

E. Minar, S. Eichinger, P. Kyrle, 1997, Thrombosis and Haemostasis.

Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis

T. Gruenberger, Michael Gnant, M. Mittlböck, 2018, Annals of surgery.

Acs:180 Results Obtained for Macroprolactinemic Samples Multiplexed Mutagenically Separated Pcr: Simulta- Neous Single-tube Detection of the Factor V R506q (g1691a), the Prothrombin G20210a, and the Methyl- Enetetrahydrofolate Reductase A223v (c677t) Variants

S. Eichinger, P. Kyrle, C. Mannhalter, 2001 .

Multiplexed mutagenically separated PCR: simultaneous single-tube detection of the factor V R506Q (G1691A), the prothrombin G20210A, and the methylenetetrahydrofolate reductase A223V (C677T) variants.

S. Eichinger, P. Kyrle, C. Mannhalter, 2001, Clinical chemistry.

Prothrombin Fragment F1+2 Is not Predictive for Recurrent Venous Thromboembolism

S. Eichinger, P. Kyrle, C. Mannhalter, 1997, Thrombosis and Haemostasis.

The role of fibrinogen plasma levels, the –455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis

D. Dunkler, C. Mannhalter, C. Zielinski, 2011, Thrombosis and Haemostasis.

Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial.

M. Posch, B. Jilma, R. Sunder-Plassmann, 2014, Journal of the American College of Cardiology.

The importance of quality assurance in molecular genetic laboratories

C. Mannhalter, C. Mannhalter, 2010, Hämostaseologie.

Thrombin as a multi-functional enzyme

A. Blann, B. Jilma, C. Mannhalter, 2011, Thrombosis and Haemostasis.

Identification of oncostatin M as a JAK2 V617F‐dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms

R. Kralovics, P. Valent, H. Gisslinger, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humans

C. Baumgartner, W. Wadsak, O. Langer, 2005, Clinical pharmacology and therapeutics.

Platelet glycoprotein Ibα polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: the association with thromboembolic disease

D. Dunkler, B. Jilma, C. Mannhalter, 2007, Annals of Hematology.

Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications

R. Sunder-Plassmann, C. Mannhalter, I. Pabinger, 2017, Annals of Hematology.

Evaluation of RNA Isolation Methods and Reference Genes for RT-PCR Analyses of Rare Target RNA

C. Mannhalter, G. Mitterbauer, D. Koizar, 2000, Clinical chemistry and laboratory medicine.

TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML

G. Superti-Furga, S. Kubicek, P. Valent, 2017, Oncotarget.

Serum-tryptase at diagnosis: a novel biomarker improving prognostication in Ph(+) CML.

P. Valent, C. Sillaber, W. Sperr, 2014, American journal of cancer research.

Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571).

O. Haas, U. Jäger, P. Valent, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Detection of Trisomy 8 in Donor-Derived Ph− Cells in a Patient with Ph+ Chronic Myeloid Leukemia Successfully Treated with Imatinib (STI571) in Relapse after Allogeneic Transplantation

O. Haas, P. Valent, W. Sperr, 2004, Leukemia & lymphoma.

Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation

P. Reitsma, M. Neumaier, P. Corbisier, 2005, Clinical chemistry and laboratory medicine.

Screening by Genomic Linkage Studies and Mutation Analysis of Hereditary Adenomatous Polyposis Coli: Usefulness for Clinical Practice

M. Zehetmayer, F. Wrba, C. Mannhalter, 1996, World Journal of Surgery.

Polymorphisms and Noncardioembolic Stroke in Three Case-Control Studies

E. Ringelstein, J. Catanese, V. Garcia, 2011, Cerebrovascular Diseases.

CYP2C9 genotype and association with bone mineral density: a pilot study.

M. Brunner, S. Brunner-Ziegler, R. Sunder-Plassmann, 2013, Gene.

CD5 Expression in a Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT)-Type as a Marker for Early Dissemination and Aggressive Clinical Behaviour

A. Chott, C. Wenzel, C. Mannhalter, 2001, Leukemia & lymphoma.

Relapse of Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: sustained molecular remission after early and dose‐escalating infusion of donor leucocytes

O. Haas, H. Greinix, F. Keil, 1997, British journal of haematology.

Evaluation of the PC-1 K121Q and G2906C variants as independent risk factors for ischaemic stroke

R. Sunder-Plassmann, C. Mannhalter, W. Lalouschek, 2011, Hämostaseologie.

Article in press-uncorrected proof Review Pharmacogenetics guided anticoagulation

R. Sunder-Plassmann, C. Mannhalter, 2010 .

Association of a Functional Polymorphism in the Clopidogrel Target Receptor Gene, P2Y12, and the Risk for Ischemic Cerebrovascular Events in Patients With Peripheral Artery Disease

E. Minar, M. Brunner, C. Mannhalter, 2005, Stroke.

Differential impact of cytochrome 2C9 allelic variants on clopidogrel-mediated platelet inhibition determined by five different platelet function tests.

R. Sunder-Plassmann, R. Koppensteiner, C. Mannhalter, 2013, International journal of cardiology.

Influence of cytochrome 2C19 allelic variants on on-treatment platelet reactivity evaluated by five different platelet function tests.

D. Moertl, R. Koppensteiner, C. Mannhalter, 2012, Thrombosis research.

Long-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.

H. Pehamberger, P. Valent, W. Sperr, 2014, American journal of blood research.

Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage

M. Steurer, P. Valent, C. Mannhalter, 2015, Annals of Hematology.

Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome

O. Wagner, G. Maurer, K. Huber, 2005, Thrombosis and Haemostasis.

Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia

H. Gisslinger, A. Tosetto, E. Missiaglia, 2002, American journal of hematology.

C-reactive protein 3' UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolism.

E. Minar, C. Mannhalter, I. Pabinger, 2006, Atherosclerosis.

Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism.

E. Minar, C. Mannhalter, I. Pabinger, 2005, Haematologica.

Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes.

O. Wagner, K. Huber, R. Marculescu, 2002, Diabetes.

The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans.

O. Wagner, R. Marculescu, B. Jilma, 2004, Clinical chemistry.

Low‐density lipoprotein receptor‐related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism

C. Mannhalter, I. Pabinger, C. Ay, 2007, Journal of thrombosis and haemostasis : JTH.

Modulation of the immunophenotype of ovarian cancer cells by N,N‐dimethylformamide and transforming growth factor‐β1

C. Dittrich, C. Mannhalter, T. Grunt, 1993 .

Interleukin-6 G(−174)C polymorphism is associated with mental retardation in cystic periventricular leucomalacia in preterm infants

C. Mannhalter, J. Haas, B. Resch, 2009, Archives of Disease in Childhood Fetal and Neonatal Edition.

The fibrinogen -148 C/T polymorphism influences inflammatory response in experimental endotoxemia in vivo.

O. Wagner, B. Jilma, C. Mannhalter, 2007, Thrombosis research.

High levels of platelet-monocyte aggregates after valve replacement for aortic stenosis: relation to soluble P-selectin and P-selectin glycoprotein ligand-1 genes.

A. Kaider, C. Mannhalter, I. Lang, 2012, Thrombosis research.

The K121Q polymorphism in the plasma cell membrane glycoprotein 1 gene predisposes to early myocardial infarction

O. Wagner, K. Huber, R. Sunder-Plassmann, 2002, Journal of Molecular Medicine.

The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebrovascular events: the influence of other vascular risk factors.

O. Wagner, C. Mannhalter, M. Schillinger, 2004, Thrombosis research.

Mean platelet volume predicts outcome in patients with asymptomatic carotid artery disease

E. Minar, R. Koppensteiner, C. Mannhalter, 2014, European journal of clinical investigation.

Autoimmune Lymphoproliferative Syndrome (ALPS) Caused by Fas (CD95) Mutation Mimicking Sarcoidosis

A. Chott, C. Mannhalter, L. Müllauer, 2008, The American journal of surgical pathology.

ENOMICS nfluence of functional haplotypes in the rug transporter gene ABCB 1 on central ervous system drug distribution in humans

C. Baumgartner, W. Wadsak, O. Langer, 2005 .

A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease

O. Wagner, K. Huber, J. Wojta, 2003, Thrombosis and Haemostasis.

Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant.

O. Wagner, K. Huber, M. Gyöngyösi, 2005, Clinical chemistry.

Is Elevated Mean Platelet Volume Associated With a Worse Outcome in Patients With Acute Ischemic Cerebrovascular Events?

C. Mannhalter, W. Lalouschek, G. Endler, 2004, Stroke.

Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events

Suzanne Cheng, O. Wagner, R. Marculescu, 2006, Clinical chemistry and laboratory medicine.

A rapid method for the isolation of genomic DNA from citrated whole blood.

C. Mannhalter, S. Parzer, 1991, The Biochemical journal.

Interleukin-6 and interleukin-6 promoter polymorphism (−174) G>C in patients with spontaneous venous thromboembolism

A. Kaider, E. Minar, C. Mannhalter, 2006, Thrombosis and Haemostasis.

Matched Case-Control Study on Factor V Leiden and the Prothrombin G20210A Mutation in Patients With Ischemic Stroke/Transient Ischemic Attack Up to the Age of 60 Years

Suzanne Cheng, C. Mannhalter, M. Schillinger, 2005, Stroke.

CYP2C9*2 and CYP2C9*3 alleles confer a lower risk for myocardial infarction.

K. Huber, J. Wojta, R. Sunder-Plassmann, 2004, Clinical chemistry.

Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease?

O. Wagner, C. Mannhalter, W. Lalouschek, 2003, British journal of haematology.

The 4G/4G genotype at nucleotide position −675 in the promotor region of the plasminogen activator inhibitor 1 (PAI‐1) gene is less frequent in young patients with minor stroke than in controls

C. Mannhalter, G. Mitterbauer, W. Lalouschek, 2000, British journal of haematology.

The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events.

C. Mannhalter, M. Schillinger, W. Lalouschek, 2003, Thrombosis research.

The effect of p 22-PHOX ( CYBA ) polymorphisms on premature coronary artery disease ( ≤ 40 years of age )

G. Maurer, K. Huber, J. Wojta, 2018 .

T‐ and B‐cell clonality and frequency of human herpes viruses‐6, ‐8 and Epstein Barr virus in angioimmunoblastic T‐cell lymphoma

R. Kusec, C. Mannhalter, M. Dominis, 2004, Hematological oncology.

Homozygosity for the C→T polymorphism at nucleotide 46 in the 5′ untranslated region of the factor XII gene protects from development of acute coronary syndrome

O. Wagner, C. Mannhalter, W. Lalouschek, 2001, British journal of haematology.

Activation of endothelium by immunotherapy with interleukin‐2 in patients with malignant disorders

O. Wagner, G. Steger, R. Mader, 1999, British journal of haematology.

Maternal interleukin-6 (−174) C/C polymorphism is associated with chorioamnionitis and cystic periventricular leucomalacia of the preterm infant

C. Mannhalter, J. Haas, B. Resch, 2010, Journal of Perinatology.

Comparison of methods for determination of interleukin 6 G(-174)C promoter polymorphism.

C. Mannhalter, G. Endler, D. Häring, 2002, BioTechniques.

Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease

K. Huber, R. Sunder-Plassmann, C. Mannhalter, 2002, British journal of haematology.

Multiplex PCR Assay for the Detection of Genetic Variants of a 1

C. Mannhalter, S. Rieger, 1999 .

The influence of thrombophilia on the long-term survival of patients with a history of venous thromboembolism

P. Kyrle, C. Mannhalter, I. Pabinger, 2012, Thrombosis and Haemostasis.

Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy

P. Kyrle, C. Mannhalter, P. Husslein, 2006, Thrombosis and Haemostasis.

The Influence of the-1639 G > A Variant on the Expression of the Vitamin K Epoxide Reductase Gene in hFOB 1 Cells

Angestrebter akademischer Grad, C. Mannhalter, 2009 .

Probability of Recurrence of Thrombosis in Patients with and without Factor V Leiden

C. Mannhalter, P. Knöbl, I. Pabinger, 1996, Thrombosis and Haemostasis.

Factor V Leiden and Prothrombin Gene G 20210 A Variant in Children with Ischemic Stroke

F. Paky, G. Höfler, K. Kaltenbrunner, 1998, Thrombosis and Haemostasis.

Prospective Evaluation of Hemostatic System Activation and Thrombin Potential in Healthy Pregnant Women with and without Factor V Leiden

A. Kaider, S. Eichinger, P. Kyrle, 1999, Thrombosis and Haemostasis.

Inhibitor development in two patients with mild haemophilia A – spontaneous disappearance and no recurrence of the inhibitor after re-challenge

R. Sunder-Plassmann, C. Mannhalter, I. Pabinger, 2012, Wiener klinische Wochenschrift.

Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women

C. Mannhalter, C. Male, I. Pabinger, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene

F. Zimprich, K. Vass, C. Mannhalter, 2005, Neurology.

Homozygous antithrombin deficiency type II causing neonatal thrombosis.

C. Mannhalter, C. Male, I. Pabinger, 2017, Thrombosis research.

No impact of endogenous prothrombotic conditions on the risk of central venous line‐related thrombotic events in children: results of the KIDCAT study (KIDs with Catheter Associated Thrombosis)

E. Mlczoch, C. Mannhalter, C. Male, 2014, Journal of thrombosis and haemostasis : JTH.

Risk of pregnancy‐associated recurrent venous thromboembolism in women with a history of venous thrombosis

A. Kaider, P. Kyrle, C. Mannhalter, 2005, Journal of thrombosis and haemostasis : JTH.

No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.

S. Eichinger, P. Kyrle, C. Mannhalter, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Prognostic value of T-cell receptor γ rearrangement in peripheral blood or bone marrow of patients with peripheral T-cell lymphomas

M. Uffmann, O. Wagner, U. Jäger, 2008, Leukemia & lymphoma.

Post-transplant acute myeloid leukemia (PT-AML)

U. Jaeger, W. Klepetko, O. Haas, 1999, Leukemia.

Resistance to activated protein C (APC): mutation at ARG506 of coagulation factor V and vascular access thrombosis in haemodialysis patients

W. Hörl, C. Mannhalter, I. Pabinger, 1996 .

Surface Adsorption of Factor XI: Association of Adsorption Sites with the Heavy Chain of Activated Factor XI

C. Mannhalter, S. Schiffman, C. Mannhalter, 1980, Thrombosis and Haemostasis.

Prekallikrein, HMW-kininogen and factor XII in various disease states.

C. Mannhalter, H. Kopsa, E. Deutsch, 1983, Thrombosis research.

Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis.

H. Gisslinger, C. Mannhalter, G. Mitterbauer, 1999, American journal of clinical pathology.

Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis.

P. Ferenci, T. Maier-Dobersberger, A. Gangl, 1995, Gastroenterology.

Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation.

D. Niederwieser, H. Greinix, C. Mannhalter, 2000, Transplantation.

Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR

U. Jaeger, O. Haas, C. Fonatsch, 1999, Leukemia.

Improved characteristics of aPC-resistance assay: Coatest aPC resistance by predilution of samples with factor V deficient plasma.

B. Jilma, C. Mannhalter, W. Speiser, 1996, American journal of clinical pathology.

The inflammatory response is influenced by FXIII VAL 34 LEU polymorphism in a human LPS model

O. Wagner, B. Jilma, C. Mannhalter, 2009, Wiener klinische Wochenschrift.

Identification of a variable number tandem repeat region in the human T cell receptor alpha-delta (TCRAD) locus

C. Mannhalter, H. Rumpold, H. Buchmayer, 1996, Human Genetics.

Molecular Disease Eradication is a Prerequisite for Long-term Remission in Patients with t(8;21) Positive Acute Myeloid Leukemia: a Single Center Study

O. Haas, U. Jäger, C. Fonatsch, 2004, Leukemia & lymphoma.

Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants

U. Jäger, C. Fonatsch, P. Höcker, 2001, Leukemia.

Polymorphisms in the coagulation factor VII gene and risk of primary intracerebral hemorrhage

C. Mannhalter, W. Lalouschek, J. Ferrari, 2007, European journal of neurology.

Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia

R. Wieser, C. Fonatsch, H. Greinix, 2003, Genes, chromosomes & cancer.

FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia

O. Haas, U. Jäger, H. Gisslinger, 1996, Annals of Hematology.

PML‐RARα PCR positivity in the bone marrow of patients with APL precedes haematological relapse by 2–3 months

U. Jaeger, K. Laczika, C. Mannhalter, 1994, British journal of haematology.

Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology.

A. Chott, C. Mannhalter, I. Mosberger, 1998, The American journal of pathology.

Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine.

R. Brezinschek, P. Neumeister, C. Mannhalter, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Unusual peripheral T cell lymphoma presenting as acute liver failure and reappearing in the liver allograft.

P. Gaulard, S. Swerdlow, A. Demetris, 2000, Transplantation.

Emergence of an unusual bone marrow precursor B-cell population in fatal Shwachman-Diamond syndrome.

G. Amann, I. Simonitsch, C. Mannhalter, 2000, Archives of pathology & laboratory medicine.

Comparison of BCR-ABL1 quantification in peripheral blood and bone marrow using an International Scale-standardized assay for assessment of deep molecular response in chronic myeloid leukemia

P. Valent, H. Esterbauer, W. Sperr, 2020, Clinical chemistry and laboratory medicine.

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia

G. Stefanzl, P. Valent, W. Sperr, 2014, Oncotarget.

Phenotyping and Target Expression Profiling of CD34+/CD38− and CD34+/CD38+ Stem- and Progenitor cells in Acute Lymphoblastic Leukemia

J. Melo, G. Stefanzl, T. Rülicke, 2018, Neoplasia.

Quantification of minimal residual disease in patients with BCR‐ABL‐positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction

U. Jaeger, N. Cross, H. Greinix, 1999, British journal of haematology.

PCR‐monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR‐ABL‐positive acute lymphoblastic leukaemia

K. Laczika, U. Jäger, H. Greinix, 1995, British journal of haematology.

PBPC mobilization with chemotherapy and G–CSF in patients with chronic myeloid leukemia: quantification of bcr/abl‐positive cells by interphase fluorescence in situ hybridization and competitive PCR

O. Haas, H. Greinix, W. Rabitsch, 2001, Transfusion.

Variant intra philadelphia translocation with rearrangement of BCR-ABL and ABL-BCR within the same chromosome in a patient with cALL.

C. Fonatsch, C. Mannhalter, G. Mitterbauer, 2000, Cancer genetics and cytogenetics.

Identification of Mutations in the Canine von Willebrand Factor Gene Associated with Type III von Willebrand Disease

J. V. van Mourik, F. Dorner, C. Mannhalter, 1998, Thrombosis and Haemostasis.

Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation.

P. Valent, H. Gadner, C. Mannhalter, 1994, Blood.

Identification of a Neoplastic Stem Cell in Human Mast Cell Leukemia

T. Rülicke, A. Reiter, P. Valent, 2014 .

The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease

P. Valent, W. Sperr, K. Gleixner, 2014, Allergy.

Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study.

U. Jaeger, D. Niederwieser, P. Kyrle, 1997, Blood.

PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus

L. Endler, O. Wagner, R. Prager, 2005, Wiener klinische Wochenschrift.

MINI-REVIEW AND REPORT OF THREE CASES Post-transplant acute myeloid leukemia (PT-AML)

U. Jaeger, O. Haas, W. Klepetko, 1999 .

Oncostatin M is a FIP1L1/PDGFRA‐dependent mediator of cytokine production in chronic eosinophilic leukemia

A. Reiter, P. Valent, A. Schmitt-Graeff, 2013, Allergy.

Molecular genetics and development of mast cells: implications for molecular medicine.

C. Mannhalter, M. Födinger, Christine Mannhalter, 1997, Molecular medicine today.

FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H☆

P. Valent, W. Sperr, C. Mannhalter, 2013, Leukemia research reports.

Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis

U. Jäger, P. Valent, H. Gisslinger, 1998, Leukemia.

Protein S Deficiency: A Database of Mutations

P. Reitsma, D. Cooper, F. Bernardi, 1997, Thrombosis and Haemostasis.

Polymorphisms in the interleukin-1 gene cluster in children and young adults with systemic meningococcemia.

R. Marculescu, C. Mannhalter, B. Resch, 2006, Clinical chemistry.

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia

A. Finn, C. Mannhalter, B. Resch, 2005, European Journal of Pediatrics.

Purification of plasma protein.

C. Mannhalter, 1988, Haemostasis.

Abstract

K. Laczika, C. Marosi, D. Fuchs, 1984, Veterinary Record.

Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation

P. Kyrle, C. Mannhalter, P. Knöbl, 2001, European journal of haematology.

A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene.

C. Mannhalter, M. Horellou, A. Zivelin, 1998, Blood.

Certification of reference materials for detection of the human prothrombin gene G20210A sequence variant

P. Corbisier, J. Márki-Zay, C. Mannhalter, 2008, Clinical chemistry and laboratory medicine.

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients – results from the Vienna Cancer And Thrombosis Study (CATS)

C. Marosi, D. Dunkler, C. Mannhalter, 2015, Journal of thrombosis and haemostasis : JTH.

[Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].

C. Mannhalter, W. Halbmayer, M. Fischer, 1993, Wiener medizinische Wochenschrift.

Combined occurrence of a heterozygous missense mutation in the protein C gene and allelic exclusion of one protein S allele leading to severe venous thrombosis.

V. Hach-Wunderle, C. Mannhalter, S. Rieger, 2001, Thrombosis research.

Anti-cardiolipin antibodies and overall survival in a large cohort: preliminary report.

O. Wagner, B. Jilma, C. Mannhalter, 2006, Clinical chemistry.

Effects of 3‐Azidothymidine on Platelet Counts, Indium‐111‐Labelled Platelet Kinetics, and Antiplatelet Antibodies

C. Mannhalter, S. Panzer, C. Stain, 1989, Vox sanguinis.

Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort study.

M. Müllner, H. Gisslinger, C. Mannhalter, 2005, Haematologica.

Increased expression of transient receptor potential canonical 6 (TRPC6) in differentiating human megakaryocytes

C. Mannhalter, Gajalakshmi Ramanathan, 2016, Cell biology international.

Multiplex PCR assay for the detection of genetic variants of α1-antitrypsin

C. Mannhalter, S. Rieger, H. Riemer, 1999 .

Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia

C. Mannhalter, S. Rieger, B. Resch, 2007, Human Genetics.

P‐selectin mRNA is maintained in platelet concentrates stored at 4°C

G. Weigel, C. Mannhalter, Gajalakshmi Ramanathan, 2009, Transfusion.

Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy.

C. Murdoch, J. Faber, A. Finn, 2006, The Pediatric infectious disease journal.

Infections and the role of plasma proteins and platelets

C. Mannhalter, 2014, Thrombosis and Haemostasis.

Monitoring neutrophils and platelets during casein‐induced anaphylaxis in an experimental BALB/c mouse model

E. Untersmayr, M. Mittlboeck, C. Mannhalter, 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Genetic fingerprinting in mouthwashes of patients after allogeneic bone marrow transplantation

H. Greinix, C. Mannhalter, G. Mitterbauer, 1999, Bone Marrow Transplantation.

Neutrophil function after exposure to polychlorinated biphenyls in vitro.

P. Ganey, C. Dittrich, C. Mannhalter, 1993, Environmental health perspectives.

Characterization and Diagnostic Work-up of a Patient with Functionally Impaired Platelet GP6

P. Bugert, C. Mannhalter, H. Eichler, 2017, Hämostaseologie.

Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.

L. Endler, O. Wagner, R. Prager, 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Are inherited thrombotic risk factors associated with fibrostenosis in Crohn's disease?

W. Reinisch, C. Lichtenberger, R. Sunder-Plassmann, 2011, Inflammatory bowel diseases.

Commercial Immunodepleted Deficient Plasmas Contain Cleaved High Molecular Weight Kininogen (HK)

C. Mannhalter, H. Lang, 1988, Thrombosis and Haemostasis.

Adsorption of coagulation factors on to haemodialysis membranes during standard haemodialysis

C. Mannhalter, P. Balcke, S. Parzer, 1993 .

Studies on the prothrombin--complex.

C. Mannhalter, E. Deutsch, H. Michl, 1979, Thrombosis research.

Donor heme oxygenase-1 genotype is associated with renal allograft function1

O. Wagner, W. Hörl, C. Mannhalter, 2004, Transplantation.

Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia

O. Haas, U. Jäger, O. Haas, 1996, Annals of Hematology.

Phospholipids accelerate factor IX activation by surface bound factor XIa

C. Mannhalter, S. Schiffman, E. Deutsch, 1984, British journal of haematology.

Protein C Promoter Genotypes Associate with Susceptibility, Development of Sepsis, and Lower Blood Pressure in Young Children with Systemic Meningococcemia

C. Mannhalter, B. Resch, W. Zenz, 2008 .

4G4G genotype of the plasminogen activator inhibitor‐1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia

C. Mannhalter, W. Zenz, G. Endler, 2007, Journal of thrombosis and haemostasis : JTH.

E-Selectin and restenosis after femoropopliteal angioplasty: prognostic impact of the Ser128Arg genotype and plasma levels

O. Wagner, E. Minar, C. Mannhalter, 2003, Thrombosis and Haemostasis.

multiple myeloma and polymorphic lymphoma of recipient origin 2 months after kidney transplantation in a heart-transplant recipient

A. Zuckermann, C. Mannhalter, K. Derfler, 2005 .

A multilocular B-cell neoplasia presenting as multiple myeloma and polymorphic lymphoma of recipient origin 2 months after kidney transplantation in a heart-transplant recipient

U. Jäger, A. Zuckermann, C. Mannhalter, 1996 .

Biocompatibility of artificial surfaces such as cellulose and related materials

C. Mannhalter, 1993 .

Preeclampsia and Fetal Loss in Women With a History of Venous Thromboembolism

A. Kaider, S. Eichinger, C. Mannhalter, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Tirofiban potentiates agonist-induced platelet activation and degranulation, despite effectively inhibiting aggregation

B. Wollenberg, C. Mannhalter, A. Verschoor, 2022, Platelets.

Is low serum bilirubin an independent risk factor for coronary artery disease in men but not in women?

O. Wagner, K. Huber, J. Wojta, 2003, Clinical chemistry.

Clinical Features of VTE and Risk Factors for Thrombosis in the Patient Group

A. Kaider, S. Eichinger, C. Mannhalter, 2001 .

Carcinogen-specific mutations in the p53 tumor suppressor gene in lung cancer.

D. Kandioler, E. Wolner, C. Mannhalter, 1994, Journal of Thoracic and Cardiovascular Surgery.

Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors

O. Haas, O. Haas, C. Fonatsch, 1998, Bone Marrow Transplantation.

Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia

U. Jaeger, K. Laczika, O. Haas, 1995, Annals of Hematology.

Hypergranular acute lymphoblastic leukemia (ALL)

M. Wolzt, C. Mannhalter, R. Scherrer, 1993, Annals of Hematology.

Quantitative monitoring of BCR/ABL1 mutants for surveillance of subclone-evolution, -expansion, and -depletion in chronic myeloid leukaemia.

T. Lion, P. Valent, W. Sperr, 2012, European journal of cancer.

Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy

C. Baumgartner, F. Zimprich, E. Stogmann, 2004, Neurology.

Simultaneous analysis of MDR1 C3435T, G2677T/A, and C1236T genotypes by multiplexed mutagenically separated PCR

M. Brunner, R. Sunder-Plassmann, C. Mannhalter, 2005, Clinical chemistry and laboratory medicine.

Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia

K. Laczika, O. Haas, U. Jäger, 2000, Annals of Hematology.

Unilateral chronic thromboembolic pulmonary disease associated with combined inherited thrombophilia.

K. Laczika, W. Klepetko, P. Kyrle, 2002, Chest.

Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia

O. Haas, W. Rabitsch, H. Greinix, 1999, Annals of Hematology.

Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A

M. Schemper, P. Neumeister, C. Mannhalter, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Biochemical and Functional Properties of Factor XI and Prekallikrein

C. Mannhalter, 1987, Seminars in Thrombosis and Hemostasis.

Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk

B. Boehm, B. Winkelmann, W. Maerz, 2008, Journal of thrombosis and haemostasis : JTH.

Evidence of a U‐shaped association between factor XII activity and overall survival

B. Jilma, C. Mannhalter, P. Quehenberger, 2007, Journal of thrombosis and haemostasis : JTH.

Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause

A. Kaider, H. Haslacher, C. Mannhalter, 2016, Annals of Hematology.

FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitors.

M. Schemper, C. Mannhalter, B. Reipert, 2016, Blood.

Influence of Imprinting of an X Chromosome and of the MethyleneTetrahydrofolate Reductase (MTHFR) 677C>T Polymorphism on FVIII Activity

R. Sunder-Plassmann, C. Mannhalter, C. Male, 2015 .

[New developments in molecularbiological diagnostic].

Christine Mannhalter, C. Mannhalter, 2017, Hamostaseologie.

The Prevalence of Moderate and Severe FXII (Hageman Factor) Deficiency among the Normal Population: Evaluation of the Incidence of FXII Deficiency among 300 Healthy Blood Donors

C. Mannhalter, R. Schön, W. Halbmayer, 1994, Thrombosis and Haemostasis.

Identification of an ancient haemophilia A splice site mutation.

A. von Haeseler, R. Sunder-Plassmann, C. Mannhalter, 2012, Thrombosis research.

677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke

C. Mannhalter, P. Schnider, W. Lalouschek, 1998, Journal of the Neurological Sciences.

Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16).

U. Jaeger, O. Haas, C. Fonatsch, 2002, The hematology journal : the official journal of the European Haematology Association.

A frequent mutation in the protein S gene results in cryptic splicing

C. Mannhalter, I. Pabinger, S. Mustafa, 1997, British journal of haematology.

High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia

H. Döhner, U. Jäger, A. Chott, 2005, Leukemia.

Protein S deficiency type I: identification of point mutations in 9 of 10 families.

C. Mannhalter, I. Pabinger, S. Mustafa, 1995, Blood.

Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia

U. Jäger, S. Stilgenbauer, C. Mannhalter, 2009, European journal of clinical investigation.

High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia

H. Döhner, U. Jäger, S. Stilgenbauer, 2004, Leukemia.

Impact-Faktor 2011 = 1,190.

C. Mannhalter, R. Scharf, 2012, Hamostaseologie.

The biological and clinical significance of MLL abnormalities in haematological malignancies

C. Mannhalter, G. Mitterbauer-Hohendanner, 2004, European journal of clinical investigation.

Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates

B. Jilma, C. Mannhalter, S. Panzer, 2003, British journal of haematology.

DNA repair polymorphisms associated with cytogenetic subgroups in B‐cell chronic lymphocytic leukemia

S. Zehetmayer, U. Jäger, C. Fonatsch, 2009, Genes, chromosomes & cancer.

Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.

B. Nadel, U. Jaeger, A. Chott, 2001, Cancer research.

Genetics of Vascular Diseases

C. Mannhalter, 2019, Fundamentals of Vascular Biology.

Chronic myeloid leukemia: Pathophysiology, diagnostic parameters, and current treatment concepts

P. Valent, C. Sillaber, M. Mayerhofer, 2003, Wiener Klinische Wochenschrift.

Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication ofHelicobacter pylori

A. Chott, G. Pohl, C. Mannhalter, 2000, Gut.

Multiplex PCR for rapid detection of T‐cell receptor‐gamma chain gene rearrangements in patients with lymphoproliferative diseases

U. Jäger, I. Simonitsch, C. Mannhalter, 1996, British journal of haematology.

Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia.

O. Haas, D. Niederwieser, H. Greinix, 1997, Blood.

Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML

G. Stefanzl, T. Holyoake, V. Sexl, 2015, Clinical Cancer Research.

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia.

G. Stefanzl, T. Rülicke, T. Holyoake, 2014, Blood.

Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL)

U. Jaeger, A. Chott, C. Skrabs, 2004, Leukemia.

Analysis of Clonal Cell Growth Using X-Chromosome Inactivation Patterns

C. Mannhalter, G. Mitterbauer, 1998, Oncology Research and Treatment.

Combined polymerase chain reaction approach for clonality detection in lymphoid neoplasms.

A. Chott, C. Mannhalter, M. Födinger, 1999, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

GAB2 is a novel target of 11q amplification in AML/MDS

F. Speleman, C. Schoch, K. Wimmer, 2006, Genes, chromosomes & cancer.

Mechanism of the chromosomal translocation t(14;18) in lymphoma: detection of a 45-Kd breakpoint binding protein.

U. Jaeger, G. Karth, S. Knapp, 1993, Blood.

Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma

U. Jaeger, P. Neumeister, I. Simonitsch, 2001, Leukemia.

Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation.

B. Nadel, U. Jäger, A. Chott, 2000, Blood.

Fixation of Brain Tumor Biopsy Specimens with RCL2 Results in Well‐Preserved Histomorphology, Immunohistochemistry and Nucleic Acids

J. Hainfellner, M. Preusser, C. Mannhalter, 2010, Brain pathology.

Trypsin activation of human factor XI.

C. Mannhalter, S. Schiffman, A. Jacobs, 1980, The Journal of biological chemistry.

Spectrum of germ-line MLH1 and MSH2 mutations in Austrian patients with hereditary nonpolyposis colorectal cancer

D. Ilencikova, F. Wrba, C. Mannhalter, 2005, Wiener klinische Wochenschrift.

Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response

R. Greil, U. Jäger, M. Putman, 2012, Haematologica.

Molecular Cytogenetic Evidence of t(14;18)(IGH;BCL2) in a Substantial Proportion of Primary Cutaneous Follicle Center Lymphomas

L. Cerroni, A. Chott, F. Trautinger, 2006, The American journal of surgical pathology.

Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia

G. Heinze, K. Laczika, U. Jäger, 1998, Leukemia.

Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia

G. Heinze, K. Laczika, O. Haas, 1997, Leukemia.

High proportion of patients with bleeding of unknown cause in persons with a mild‐to‐moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB)

S. Eichinger, P. Kyrle, H. Haslacher, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

ABO mismatch increases transplant‐related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation

H. Greinix, P. Höcker, F. Keil, 2003, Transfusion.

Molekularbiologie und Hämostase

C. Mannhalter, 2008, Hämostaseologie.

Immunoreactivity of B-Cell Markers (CD79a, L26) in Rare Cases of Extranodal Cytotoxic Peripheral T- (NK/T-) Cell Lymphomas

W. Jurecka, A. Chott, C. Mannhalter, 2000, Modern Pathology.

Clinical features of thrombophilia in families with gene defects in protein C or protein S combined with factor V Leiden.

P. Kyrle, C. Mannhalter, P. Knöbl, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Twelve novel and two recurrent mutations in 14 Austrian families with hereditary protein C deficiency

P. Reitsma, R. Bertina, C. Mannhalter, 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

A hitherto unknown splice site defect in the protein S gene (PROS1): the mutation results in allelic exclusion and causes type I and type III protein S deficiency

C. Mannhalter, H. Schwarz, I. Pabinger, 1997, British journal of haematology.

Prospective Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia with Inversion(16) by CBFβ/MYH11 RT-PCR: Implications for a Monitoring Schedule and for Treatment Decisions

U. Jaeger, K. Laczika, C. Fonatsch, 2001, Leukemia & lymphoma.

Clotting activities and antigen concentrations of contact factors in kidney disease.

C. Mannhalter, H. Kopsa, E. Deutsch, 1985, Thrombosis research.

Genetic variations and their influence on risk and treatment of venous thrombosis.

J. Leitner, B. Jilma, C. Mannhalter, 2008, Pharmacogenomics.

Factor VII gene haplotypes and risk of ischemic stroke.

C. Mannhalter, M. Schillinger, W. Lalouschek, 2006, Clinical chemistry.

Factor XII activity and antigen concentrations in patients suffering from recurrent thrombosis

C. Mannhalter, P. Hopmeier, E. Deutsch, 1987 .

CRM+ severe Fletcher factor deficiency associated with Graves' disease.

P. Kyrle, C. Mannhalter, H. Niessner, 1984, Haemostasis.

Human high molecular weight kininogen. Effects of cleavage by kallikrein on protein structure and procoagulant activity.

C. Mannhalter, S. Schiffman, K. Tyner, 1980, The Journal of biological chemistry.

Possible clinical effects of the interaction of hemodialysis membranes with adhesion proteins.

C. Mannhalter, U. Seyfert, S. Baumgartner‐Parzer, 1995, Kidney international.

Plasma protein adsorption to hemodialysis membranes: studies in an in vitro model.

C. Mannhalter, P. Balcke, S. Parzer, 1993, Journal of biomedical materials research.

Identification of a defective factor XI cross-reacting material in a factor XI-deficient patient.

C. Mannhalter, E. Deutsch, P. Hellstern, 1987, Blood.

The effect of synthetic polymer surfaces on the activation of factor XI in plasma: influence of heparin.

C. Mannhalter, E. Deutsch, 1984, Thrombosis research.

Contact Activation of Factor XI

R. Margalit, C. Mannhalter, S. Schiffman, 1981, British journal of haematology.

Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score.

W. März, O. Wagner, G. Maurer, 2012, European heart journal.

Gene Polymorphisms and Signaling Defects

M. Poteser, C. Mannhalter, K. Groschner, 2013 .

Identification of the target platelet glycoprotein in autoimmune thrombocytopenia occurring after allogeneic bone marrow transplantation

C. Mannhalter, K. Lechner, C. Mueller-Eckhardt, 1989, Blut.

Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemia

W. Rabitsch, H. Greinix, F. Keil, 1998, Annals of Hematology.

Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusion

O. Haas, H. Greinix, P. Kalhs, 1996, British journal of haematology.

RAPID ESTABLISHMENT OF LONG‐TERM CULTURE‐INITIATING CELLS OF DONOR ORIGIN AFTER NONMYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM‐CELL TRANSPLANTATION, AND SIGNIFICANT PROGNOSTIC IMPACT OF DONOR T‐CELL CHIMERISM ON STABLE ENGRAFTMENT AND PROGRESSION‐FREE SURVIVAL

H. Greinix, W. Rabitsch, F. Keil, 2003, Transplantation.

Abstracts of the 8th European Symposium on Platelet and Granulocyte Immunobiology, Seehotel Rust, Rust, Austria, May 13–16, 2004

W. Ouwehand, W. Mayr, C. Mannhalter, 2004 .

Biomarkers for arterial and venous thrombotic disorders

C. Mannhalter, 2014, Hämostaseologie.

Plasminogen activator inhibitor-1 and outcome after femoropopliteal angioplasty: analysis of genotype and plasma levels

O. Wagner, E. Minar, C. Mannhalter, 2003, Thrombosis and Haemostasis.

Impact of Escherichia coli K12 and O18:K1 on human platelets: Differential effects on platelet activation, RNAs and proteins

T. Wurdinger, M. Best, H. Verschueren, 2018, Scientific Reports.

An unusual case of myelodysplastic syndrome with prolonged clonal stability, indolent clinical course over a decade, and spontaneous regression of AML in the terminal phase

O. Haas, C. Fonatsch, P. Valent, 2005, European journal of haematology.

Interleukin-1 cluster combined genotype and restenosis after balloon angioplasty

O. Wagner, E. Minar, R. Marculescu, 2003, Thrombosis and Haemostasis.

Impact of αENaC Polymorphisms on the Risk of Ischemic Cerebrovascular Events: A Multicenter Case–Control Study

Suzanne Cheng, O. Wagner, C. Mannhalter, 2005 .

Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.

C. Mannhalter, T. Bachleitner-Hofmann, H. Taghizadeh, 2017, Surgical oncology.

Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor.

O. Wagner, F. Bach, M. Müllner, 2004, Journal of the American College of Cardiology.

Heme Oxygenase-1 Genotype is a Vascular Anti-inflammatory Factor following Balloon Angioplasty

O. Wagner, R. Ahmadi, E. Minar, 2002, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm.

O. Wagner, K. Huber, E. Minar, 2002, Thrombosis research.

Regular Article Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm

O. Wagner, K. Huber, E. Minar, 2002 .

Heme Oxygenase-1 Gene Promoter Microsatellite Polymorphism is Associated with Restenosis after Percutaneous Transluminal Angioplasty

O. Wagner, M. Haumer, E. Minar, 2001, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

Age-specific PCA3 score reference values for diagnosis of prostate cancer

T. Klatte, M. Remzi, C. Mannhalter, 2012, World Journal of Urology.

Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome

G. Ott, U. Jaeger, A. Chott, 2004, Leukemia.

Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation

O. Haas, A. Chott, J. Ackermann, 1999, Annals of Hematology.

Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia

T. Lion, C. Bock, P. Valent, 2016, Leukemia.

Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia.

C. Guillemette, U. Jaeger, S. Zehetmayer, 2013, Blood.

The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma.

H. Pehamberger, O. Wagner, F. Roka, 2006, The Journal of investigative dermatology.

Low transplant-related mortality in patients receiving unrelated donor marrow grafts for leukemia

W. Rabitsch, H. Greinix, F. Keil, 1999, Bone Marrow Transplantation.

Detection of engraftment and mixed chimerism following bone marrow transplantation using PCR amplification of a highly variable region-variable number of tandem repeats (VNTR) in the von Willebrand factor gene

C. Marosi, O. Haas, A. Gaiger, 1991, Annals of Hematology.

Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas.

C. Marosi, A. Kaider, C. Mannhalter, 2014, Neuro-oncology.

Continuous complete clinical and molecular remission in two patients with refractory lymphoid malignancies after autografting followed by allogeneic stem cell transplantation with reduced intensity conditioning

H. Gisslinger, H. Greinix, F. Keil, 2002, British journal of haematology.

Alternative end-joining in follicular lymphomas’ t(14;18) translocation

B. Nadel, U. Jaeger, A. Chott, 2002, Leukemia.

Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism.

A. Kaider, P. Kyrle, C. Mannhalter, 2002, Blood.

High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V

K. Sotlar, P. Valent, W. Sperr, 2010, Molecular oncology.

Molecular genetic differentiation between primary lung cancers and lung metastases of other tumors.

G. Dekan, D. Kandioler, E. Wolner, 1996, The Journal of thoracic and cardiovascular surgery.

A Meta-Analysis of Candidate Gene Polymorphisms and Ischemic Stroke in 6 Study Populations: Association of Lymphotoxin-Alpha in Nonhypertensive Patients

Li-sheng Liu, N. Cook, P. Ridker, 2009, Stroke.

The relation between erythrocyte volume and folate levels is influenced by a common mutation in the methylenetetrahydrofolate reductase (MTHFR) gene (C677T).

L. Deecke, W. Serles, C. Mannhalter, 2000, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism

C. Mannhalter, I. Pabinger, C. Ay, 2007, Thrombosis and Haemostasis.

Homocysteine levels in polycythaemia vera and essential thrombocythaemia

H. Gisslinger, C. Mannhalter, F. Rodeghiero, 1999, British journal of haematology.

The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia.

O. Wagner, B. Jilma, R. Sunder-Plassmann, 2006, Clinical chemistry.

Fractalkine receptor polymorphisms V249I and T280M as genetic risk factors for restenosis

O. Wagner, G. Maurer, K. Huber, 2005, Thrombosis and Haemostasis.

Risk of recurrence after a first venous thromboembolic event in young women

A. Kaider, C. Mannhalter, I. Pabinger, 2007, Haematologica.

Risk of recurrence after a first venous thromboembolic event in young women.

A. Kaider, C. Mannhalter, I. Pabinger, 2007, Haematologica.

Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases.

M. Tiemann, G. Ott, M. Stolte, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2.

L. Endler, O. Wagner, K. Huber, 2003, Thrombosis research.

Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.

W. Hörl, C. Mannhalter, I. Pabinger, 1997, Kidney international.

Faktor XI: Physiologie, Biochemie, Molekularbiologie

C. Mannhalter, 1999 .

The impact of uric acid on long-term mortality in patients with asymptomatic carotid atherosclerotic disease.

E. Minar, R. Koppensteiner, C. Mannhalter, 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A

F. Rosendaal, C. Mannhalter, I. Pabinger, 2004, Journal of thrombosis and haemostasis : JTH.

The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (≤ 40 years of age)

G. Maurer, K. Huber, J. Wojta, 2010, Thrombosis and Haemostasis.

Defective diacylglycerol‐induced Ca2+entry but normal agonist‐induced activation responses in TRPC6‐deficient mouse platelets

B. Nieswandt, A. Dietrich, C. Mannhalter, 2012, Journal of thrombosis and haemostasis : JTH.

Interleukin-6 promoter genotype and restenosis after femoropopliteal balloon angioplasty: initial observations.

O. Wagner, E. Minar, C. Mannhalter, 2004, Radiology.

The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.

Klaus Lechner, Christine Mannhalter, Ansgar Weltermann, 2002, Archives of internal medicine.

Rapid neonatal diagnosis of type IIB von Willebrand disease using the polymerase chain reaction.

P. Kyrle, C. Mannhalter, K. Lechner, 1991, Blood.

Common IgE-epitopes of recombinant Phl p I, the major timothy grass pollen allergen and natural group I grass pollen isoallergens.

R. Valenta, C. Mannhalter, M. Duchêne, 1996, Molecular immunology.

The VKORC1 polymorphism rs9923231 is associated with aneurysms of the ascending aorta in an Austrian population.

M. Wolzt, C. Mannhalter, M. Ehrlich, 2017, Thrombosis research.

Combined haplotypes of protein C and endothelial protein C receptor

C. Mannhalter, B. Resch, W. Zenz, 2009, Hämostaseologie.

C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study.

L. Deecke, W. Serles, C. Mannhalter, 1999, Thrombosis research.

Haem oxygenase‐1 genotype and cardiovascular adverse events in patients with peripheral artery disease

O. Wagner, E. Minar, C. Mannhalter, 2005, European journal of clinical investigation.

Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis

O. Wagner, S. Zehetmayer, E. Minar, 2012, European journal of clinical investigation.

A microsatellite polymorphism in the heme oxygenase‐1 gene promoter is associated with risk for melanoma

H. Pehamberger, O. Wagner, C. Mannhalter, 2006, International journal of cancer.

Impact of Escherichia coli K12 and O18:K1 on human platelets: Differential effects on platelet activation, RNAs and proteins

T. Wurdinger, M. Best, H. Verschueren, 2018, Scientific Reports.

Candidate genetic risk factors of stroke: results of a multilocus genotyping assay.

Suzanne Cheng, O. Wagner, C. Mannhalter, 2007, Clinical chemistry.

Major determinants of hyperhomocysteinemia in peritoneal dialysis patients.

W. Hörl, C. Mannhalter, G. Sunder-Plassmann, 1998, Kidney international.

The Thr715Pro Polymorphism of the P-Selectin Gene Is Not Associated With Ischemic Stroke Risk

C. Mannhalter, S. Rieger, W. Lalouschek, 2007, Stroke.

Thrombophilic polymorphisms – factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations – and preterm birth

C. Mannhalter, W. Muntean, B. Resch, 2004, Wiener klinische Wochenschrift.

Association between the rs342293 polymorphism and adverse cardiac events in patients undergoing percutaneous coronary intervention

G. Maurer, B. Jilma, C. Mannhalter, 2014, Thrombosis and Haemostasis.

Polymorphism of the palladin gene and cardiovascular outcome in patients with atherosclerosis

O. Wagner, E. Minar, R. Koppensteiner, 2011, European journal of clinical investigation.

Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.

W. Hörl, C. Mannhalter, I. Pabinger, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Vitamin K epoxide reductase (VKORC1) gene mutations in osteoporosis: A pilot study.

S. Zehetmayer, C. Bieglmayer, C. Mannhalter, 2010, Translational research : the journal of laboratory and clinical medicine.

Vienna Stroke Registry. Impact of the platelet glycoprotein Ib alpha Kozak polymorphism on the risk of ischemic cerebrovascular events: a case–control study

C. Mannhalter, M. Schillinger, W. Lalouschek, 2004, Blood Coagulation and Fibrinolysis.

mutationof homozygotes for the 845G>A (C282Y) hereditary hemochromatosis promoter polymorphisms and liver abnormalities a Tumor necrosis factor

J. Basecke, L. Cepek, C. Mannhalter, 2002 .

Deep Venous Thrombosis of the Lower Extremity in a 16-Year-Old Girl with Homozygous MTHFR- and Heterozygous Factor V Leiden-Mutation

C. Mannhalter, W. Muntean, M. Koestenberger, 2004 .

Association of periprocedural neurological deficit in carotid stenting with increased anticardiolipin antibodies.

E. Minar, A. Hammer, R. Koppensteiner, 2009, Thrombosis research.

High Levels of Soluble P-Selectin Are Associated with the Risk of Venous Thromboembolism and the P-Selectin Thr715 Variant.

A. Kaider, C. Mannhalter, I. Pabinger, 2006 .